Please login to the form below

Not currently logged in
Email:
Password:

Mallinckrodt

This page shows the latest Mallinckrodt news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca forms $2bn gene silencing pact with Silence Tx

AstraZeneca forms $2bn gene silencing pact with Silence Tx

tissues. This is the second $2bn-plus alliance for Silence, coming after Irish drugmaker Mallinckrodt paid $25m upfront last year for a project that will develop siRNA drugs targeting the complement

Latest news

More from news
Approximately 11 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    Patent settlement, non-exclusive licence. 200. Mallinckrodt/Baxter International. RECOTHROM Thrombin topical and PREVELEAK Surgical Sealant to control bleeding in surgery.

  • Pharma deals continue to slide Pharma deals continue to slide

    products. While this may not have been the reason behind GSK’s termination of its rare disease projects, it has not deterred Mallinckrodt from acquiring Infacare, a US company with a ... 469 (upfront 31). Infacare (US). Mallinckrodt (US/GB). Company

  • Deal Watch August 2016 Deal Watch August 2016

    Mallinckrodt (US) Nuclear Imaging business. IBA Molecular (BE). Asset acquisition. Diagnostic imaging products for use in nuclear medicine including molybdenum-99.

  • Pharma deals in August 2015 Pharma deals in August 2015

    30600. Therakos. Mallinckrodt. Approved cell therapy platform for the palliative treatment of cutaneous T‐cell lymphoma [CTCL].

  • Medius Deal Watch table for March 2015 Medius Deal Watch table for March 2015

    3, 500. Ikaria / Mallinckrodt. Company acquisition. Marketed critical care treatments incl.

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

Switzerland
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
Responding to dynamic shifts in value communications
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
Doing what we can and having fun doing it: our fundraising month
Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...

Infographics